Skip to main content
Axogen, Inc. logo

Axogen, Inc. — Investor Relations & Filings

Ticker · AXGN ISIN · US05463X1063 US Manufacturing
Filings indexed 1,140 across all filing types
Latest filing 2020-02-05 Major Shareholding Noti…
Country US United States of America
Listing US AXGN

About Axogen, Inc.

https://www.axogeninc.com/

Axogen, Inc. is a regenerative medicine company focused on developing and commercializing surgical solutions for peripheral nerve repair. The company provides technologies designed to restore sensation and functionality to individuals with damaged peripheral nerves. Its portfolio is centered on products that facilitate nerve regeneration and repair, such as the Avance® Nerve Graft, a processed human nerve allograft for bridging nerve gaps. Axogen's solutions are utilized by surgeons to treat patients with nerve injuries resulting from trauma or other medical conditions, aiming to improve their quality of life by restoring function and reducing pain.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2020
Major Shareholding Notification
2020-02-05 English
FORM 4 -
Director's Dealing
2020-01-18 English
8-K
Regulatory Filings
2020-01-13 English
SCHEDULE 13G HOLDINGS REPORT AMENDMENT
Major Shareholding Notification
2020-01-10 English
FORM 4 -
Director's Dealing
2020-01-03 English
FORM 4 -
Director's Dealing
2019-12-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.